Search

Tate & Lyle PLC

Geschlossen

BrancheKonsumgüter defensiv

365 0.5

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

355.4

Max

365.4

Schlüsselkennzahlen

By Trading Economics

Einkommen

78M

56M

Verkäufe

63M

1B

KGV

Branchendurchschnitt

52.286

28.085

EPS

0.2

Dividendenrendite

5.45

Gewinnspanne

5.469

Angestellte

5,000

EBITDA

95M

188M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+17.42% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

5.45%

3.68%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-5.3M

1.6B

Vorheriger Eröffnungskurs

364.5

Vorheriger Schlusskurs

365

Nachrichtenstimmung

By Acuity

32%

68%

38 / 147 Ranking in Consumer defensive

Tate & Lyle PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Jan. 2026, 23:11 UTC

Ergebnisse

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7. Jan. 2026, 22:55 UTC

Wichtige Markttreiber

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7. Jan. 2026, 21:39 UTC

Wichtige Markttreiber

Raytheon Down Following Trump Post Criticizing Company

7. Jan. 2026, 20:13 UTC

Wichtige Markttreiber

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7. Jan. 2026, 20:03 UTC

Wichtige Markttreiber

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7. Jan. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7. Jan. 2026, 23:46 UTC

Market Talk

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7. Jan. 2026, 23:42 UTC

Akquisitionen, Fusionen, Übernahmen

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7. Jan. 2026, 23:34 UTC

Market Talk

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7. Jan. 2026, 23:29 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7. Jan. 2026, 22:48 UTC

Market Talk

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7. Jan. 2026, 22:46 UTC

Ergebnisse

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7. Jan. 2026, 22:45 UTC

Ergebnisse

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7. Jan. 2026, 22:43 UTC

Akquisitionen, Fusionen, Übernahmen

Revolution Medicines Draws Takeover Interest -- 2nd Update

7. Jan. 2026, 22:42 UTC

Ergebnisse

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7. Jan. 2026, 22:41 UTC

Ergebnisse

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7. Jan. 2026, 22:41 UTC

Ergebnisse

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7. Jan. 2026, 22:40 UTC

Wichtige Markttreiber

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7. Jan. 2026, 22:31 UTC

Market Talk

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7. Jan. 2026, 22:22 UTC

Market Talk

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7. Jan. 2026, 22:01 UTC

Market Talk

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7. Jan. 2026, 21:46 UTC

Market Talk

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7. Jan. 2026, 21:22 UTC

Akquisitionen, Fusionen, Übernahmen

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7. Jan. 2026, 21:18 UTC

Akquisitionen, Fusionen, Übernahmen

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7. Jan. 2026, 21:05 UTC

Akquisitionen, Fusionen, Übernahmen

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7. Jan. 2026, 20:29 UTC

Akquisitionen, Fusionen, Übernahmen

AbbVie Near Deal for Revolution Medicines -- Update

7. Jan. 2026, 20:27 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7. Jan. 2026, 19:58 UTC

Market Talk

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7. Jan. 2026, 19:48 UTC

Wichtige Markttreiber

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Tate & Lyle PLC Prognose

Kursziel

By TipRanks

17.42% Vorteil

12-Monats-Prognose

Durchschnitt 425.52 GBX  17.42%

Hoch 500 GBX

Tief 367.6 GBX

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Tate & Lyle PLC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

5 ratings

1

Buy

4

Halten

0

Sell

Stimmung

By Acuity

38 / 147 Ranking in Konsumgüter defensiv

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Tate & Lyle PLC

Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverage, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. The company operates through three segments: Food & Beverage Solutions, Sucralose, Primary Products Europe, and Primient. It offers dairy products, soups, sauces, and dressings; bakery products and snacks; texturants; sweeteners, such as high fructose corn syrup and dextrose; industrial starches; acidulants; and corn gluten feed and meal and corn oil. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
help-icon Live chat